SCHEMBL30237017

SCHEMBL30237017

CNc1cc2ncc(-c3cc(NC(=O)c4cc(C(C)(C)C#N)ccn4)cnc3C)cc2cn1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.60
▸ RAF1 P04049 19/20 0.60
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29272226 1.00 BRAF (0.60) BRAFRAF1CYP2C9
SCHEMBL29272314 0.91 RAF1 (0.57) BRAFRAF1
SCHEMBL30237025 0.91 RAF1 (0.57) BRAFRAF1
SCHEMBL30236315 0.91 BRAF (0.59) BRAFRAF1CYP2C9
SCHEMBL29272322 0.91 BRAF (0.59) BRAFRAF1CYP2C9
SCHEMBL30236993 0.90 BRAF (0.51) BRAFRAF1CYP2C9
SCHEMBL29272252 0.90 BRAF (0.51) BRAFRAF1CYP2C9
SCHEMBL30236561 0.90 BRAF (0.50) BRAFRAF1CYP2C9
SCHEMBL30236434 0.89 RAF1 (0.58) BRAFRAF1
SCHEMBL29272231 0.89 RAF1 (0.58) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399210-A1 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES Black Diamond Therapeutics, Inc. (US) 2024-07-17 — — EP disclosed
CN-118159537-A 6-Aza-quinoline derivatives and related uses 黑钻治疗公司 2024-06-07 — — CN disclosed
WO-2023039505-A1 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2023-03-16 — — WO disclosed
Send feedback